Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2017-12-21 16:08:59
Reporting Period:
Accepted Time:
2017-12-21 16:08:59
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1371217 Reshape Lifesciences Inc. RSLS Electromedical & Electrotherapeutic Apparatus (3845) 481293684
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1642607 Y Michael Mashaal 2800 Patton Road
St. Paul MN 55113
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.01 Par Value Per Share Acquisiton 2017-12-19 2,048,700 $0.00 2,617,077 No 4 C Indirect See footnote
Series C Convertible Preferred Stock, $0.01 Par Value Disposition 2017-12-19 20,487 $0.00 26,200 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect See footnote
No 4 S Indirect See footnote
  1. Each share of Series C Convertible Preferred Stock converted into 100 shares of common stock.
  2. Consists of shares held directly by HealthCor Partners Fund II, L.P. ("HCPII"). The shares held by HCPII may be deemed to be beneficially owned by HealthCor Partners II, L.P. ("HCP2LP"), its general partner, and by HealthCor Partners GP, LLC ("HCPGP"), the general partner of HCP2LP. Dr. Mashaal is a managing director of HealthCor Partners Management, L.P. ("HCP Management"), which is the investment manager to HCPII, and may be deemed to have shared voting and investment power over such shares. Each of HCPLP, HCP2LP, HCPGP, HCP Management and Dr. Mashaal hereby disclaims any beneficial ownership of shares held by HCPII except to the extent of any pecuniary interest therein.